Introduction
It has been recognized that periodontitis is an infectious condition, and that periodontal attachment loss results from interaction between specific anaerobic bacteria and host immune mechanisms (1) . A recent study has indicated that multibacterial infection and certain combinations of periodontopathogens, including Porphyromonas gingivalis, Tannerella forsythesis, Prevotella intermedia and Fusobacterium nucleatum, are involved in the pathogenesis of periodontitis (2) . Short-chain fatty acids (SCFA) (e.g., butyric acid, lactic acid and propionic acid) are bacterial metabolic by-products with significant biological activities, including the ability to alter cell proliferation, gene expression and apoptosis (3) (4) (5) . Periodontal bacteria, in particular, release millimolar concentrations of SCFA into their environment (1) , and these acids have been used to characterize the bacteria. Moreover, SCFA stimulates gingival inflammation via release of proinflammatory cytokines (6) . Butyric acid (sodium butyrate; BA) is a major metabolic by-product of the main periodontopathic bacteria present in subgingival plaque (2, 7, 8) . Culture media used for growth of Porphyromonas gingivalis, Prevotella loescheii and Fusobacterium nucleatum can contain 13.3-26.8 mM butyric acid (1) , and the concentration of butyric acid in subgingival plaque from patients with periodontitis can reach 14.4-20 mM; also its concentration in periodontal pockets has been shown to correlate with the severity of periodontal disease (9) . Inflamed gingival fibroblasts from adult patients with periodontitis appear to be highly susceptible to mitochondria-and caspase-dependent apoptosis induced by BA, in comparison with healthy gingival fibroblasts (5).
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Moreover, BA is a potent inhibitor of histone deacetylases (HDACs) (10) .
Bone sialoprotein (BSP) is a major non-collagenous protein found in mineralized connective tissues, and has been implicated in the nucleation of hydroxyapatite (11) (12) (13) . Studies on the developmental expression of BSP have shown that BSP mRNA is produced at high levels at the onset of bone, dentin and cementum formation (14) . BSP is also expressed by breast, prostate and lung cancers and is associated with the formation of ectopic hydroxyapatite microcrystals in tumor tissues and tumor metastases (13, 15) . The rat, mouse and human BSP genes have been cloned and partially characterized (16) (17) (18) (19) (20) , and their promoters contain an inverted TATA box (-24 to -19) (21), an inverted CCAAT box (-50 to -46) (22, 23) , a cAMP response element (CRE; -75 to -68) (24) (25) (26) , a fibroblast growth factor 2 (FGF2) response element (FRE; -92 to -85) (24, (27) (28) (29) (30) , a pituitary-specific transcription factor-1 (Pit-1) motif (-111 to -105) (31) , and a homeodomain protein binding site (HOX; -199 to -192) (30, 32, 33) .
There have been a number of recent studies examining the effect of BA on the differentiation of many types of cells (34) (35) (36) (37) , and it has been suggested that BA promotes the differentiation and maturation of osteoblasts. Furthermore, BA stimulates mineralized nodule formation by increasing the gene and protein expression levels of type I collagen, osteopontin and BSP (38) . In the present study, we analyzed the effects of BA on BSP gene transcription in rat osteoblast-like ROS17/2.8 cells.
Materials and Methods

Materials
Alpha minimum essential medium (α-MEM), fetal calf serum (FCS), Lipofectamine, penicillin, streptomycin, and trypsin were obtained from Invitrogen (Carlsbad, CA, USA). The pGL3-basic and pSV-β-galactosidase (β-Gal) control vectors were purchased from Promega Co. (Madison, WI, USA). Butyric acid was purchased from Sigma-Aldrich (Steinheim, Germany). Rat osteoblast-like ROS17/2.8 cells were a gift from Dr. Jaro Sodek (39) . All chemicals used were of analytical grade.
Cell culture ROS17/2.8 cells were first grown to confluence in 60-mm tissue culture dishes in α-MEM containing 10% FCS, then cultured in α-MEM without serum, followed by incubation with BA at doses ranging from 10 -8 to 10 -2 M for 12 h, or for 3-12 h at 10 -4 M. Total RNA was isolated from triplicate cultures.
Northern hybridization
After BA treatment, total RNA was extracted from ROS17/2.8 cells using guanidinium thiocyanate. Aliquots (20 µg) of total RNA were fractionated in 1.2% agarose gels and transferred to a Hybond-N+ membrane. Hybridizations were performed at 42°C with 32 P-labeled rat BSP and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probes. The hybridized bands, representing the two polyadenylated forms (1.6 and 2.0 kb) of rat BSP mRNA, were scanned using a Bio-imaging analyzer (Fuji BAS2500).
Transient transfection assays
Exponentially growing ROS17/2.8 cells were used for transfection assays. Twenty-four hours after plating, cells at 40-60% confluence were transfected using Lipofectamine reagent, 1 µg of a luciferase (LUC) construct, and 2 µg of β-Gal vector as an internal control. Two days after transfection, the cells were deprived of serum for 12 h, and then BA (10 -4 M) was added for 12 h prior to harvest. The luciferase assay was performed in accordance with the supplier's protocol using a luminescence reader (Acuu Flex Lumi 400; Aloka, Tokyo, Japan) for measurement of luciferase activities.
Gel mobility shift assays Confluent ROS17.2.8 cells in T-75 flasks incubated for 3, 6 and 12 h with 10 -4 M BA in α-MEM without serum were used to prepare nuclear extracts. Nuclear protein was extracted according to the method of Dignam et al. (40) with the addition of extra proteinase inhibitors (extraction buffer contained 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol (DTT), 25% (v/v) glycerol, 0.5 mM phenylmethyl-sulfonyl fluoride, 2 µg/ml leupeptin, 2 µg/ml pepstatin A, 1 µg/ml aprotinin, pH 7.9). Double-stranded oligonucleotides encompassing the inverted CCAAT (nts, -61 to -37, 5'-CCGTGACCGTG ATTGGCTGCTGAGA), CRE (nts, -84 to -59, 5'-CCCACAGCCTGACGTCGCACCGGCCG), FRE (nts, -98 to -79, 5'-TTTTCTGGTGAGAACCCACA), Pit-1 (nts, -115 to -96, 5'-CGTGTTGTAGTTACGGATTT) and HOX (nts, -204 to -179, 5'-TCCTCAGCCT TCAATTAAATCCCACA) motifs in the rat BSP promoter were prepared. For gel shift analysis, double-stranded oligonucleotides were end-labeled with [γ-32 P]ATP and T4 polynucleotide kinase. Nuclear protein extracts (3 µg) were incubated for 20 min at room temperature with 0.1 pM radiolabeled double-stranded oligonucleotide, and then the protein-DNA complexes were resolved by electrophoresis on 5% non-denaturing acrylamide gels (38:2 acrylamide/bis acrylamide) run at 200 V at RT.
After electrophoresis, the gels were dried, and then autoradiograms were prepared and analyzed using an image analyzer.
Statistical analysis
Triplicate or quadruplicate samples were analyzed for each experiment, and the experiments were replicated to ensure the consistency of the responses to BA. Significance of differences between the control and BA treatments was determined using unpaired Student's t-test. -6 and 10 -4 M, and the maximal effect was observed at 10 -4 M, whereas 10 -2 M BA down-regulated the expression of BSP mRNA (Fig. 1A) . This optimal level of BA was used to determine the time course of BSP mRNA expression. BA up-regulated the BSP mRNA level at 12 h, but no effect on GAPDH was observed (Fig. 1B) .
Results
Stimulation
Transient transfection analysis of rat BSP promoter constructs
To further determine the effects of BA on the activation of BSP transcription, various-sized rat BSP promoters ligated to a luciferase reporter gene (pLUC1 -pLUC6, pLUC1; -18 to +60, pLUC2; -43 to +60, pLUC3; -116 to +60, pLUC4; -425 to +60, pLUC5; -801 to +60 and pLUC6; -938 to +60) were transiently transfected into ROS17/2.8 cells. The results of luciferase assays indicated increases in transcription after 12 h of treatment with 10 -4 M BA using the pLUC3, pLUC4, pLUC5 and pLUC6 constructs (Fig. 2) . With shorter constructs (pLUC1 and pLUC2), luciferase activities were not increased by BA. The DNA sequence of the pLUC3 construct contains a unique inverted CCAAT box (ATTGG; nts -50 and -46), and CRE (nts -75 and -68), Runx2 (nts -84 and -79), FRE (nts -92 and -85) and Pit-1 (nts -111 and -105) motifs (Fig.  3) . To determine more precisely the target sites in the BSP promoter through which the BA effect was mediated, we introduced 2-bp mutations in the putative response elements targeted by BA in pLUC3 (M-CCAAT, M-CRE and M-FRE) (Fig. 4) . After introduction of these mutations, the basal activities of M-CCAAT, M-CRE and M-FRE were lower than the basal transcriptional activity of pLUC3. Transcriptional induction by BA was abrogated in M-FRE (Fig. 4) .
Gel mobility shift assay
To identify nuclear proteins that bind to CCAAT, CRE, FRE, Pit1 and HOX, double-stranded oligonucleotides were end-labeled and incubated with equal amounts (3 µg) of nuclear proteins extracted from confluent ROS17/2.8 cells that were either not treated (control) or treated with BA (10 -4 M) for 3, 6 and 12 h. When we used the inverted CCAAT and HOX as probes, the DNA-protein complexes did not change after BA treatment (Fig. 5, lanes 1-4, 17-20) . With nuclear extracts from confluent control cultures of ROS17/2.8 cells, shift of the FRE-protein complex was evident (Fig. 5, lane 9) . After stimulation by BA (3-12 h) , FRE-protein complex formation was increased at 3, 6 and 12 h (Fig. 5, lanes 10-12) . BA did not induce formation of CRE-or Pit-1-protein complexes (Fig. 5, lanes 5-8, 13-16 ).
Discussion
BA induced the expression of BSP mRNA at 12 h in ROS17/2.8 cells (Fig. 1) . The concentration of BA in subgingival plaque from periodontal pockets reportedly reaches 14.4 to 20 mM (1, 9) . While BA at 10 mM downregulated the expression of BSP mRNA, at 0.1 mM (10 -4 M) the expression of BSA mRNA was increased (Fig. 1A) . Our results suggested that a low concentration of BA was able to induce bone formation. Transient transfection assays demonstrated that the luciferase activity of pLUC3 and M-FRE (GGcaAGAA) constructs were analyzed for relative promoter activity after transfection into ROS17/2.8 cells, and examined for induction after treatment with BA (10 -4 M) for 12 h. The results of transcriptional activity obtained from four separate transfections with the constructs were combined, and the values are expressed with standard errors. Significant differences from control: *** ( P < 0.02); **** ( P < 0.01).
was increased by BA (10 -4 M, 12 h), suggesting that factors binding to the promoter region of pLUC3 are crucial for BA-induced BSP transcription. The results of the mutation luciferase assay suggested that FRE is required for optimal induction of BSP transcription by BA (Fig. 4) . The involvement of FRE in the regulation of BSP transcription by BA was confirmed in the gel mobility shift assays; the formation of FRE-protein complex was increased at 3, 6 and 12 h upon treatment with BA (Fig. 5) .
Transcription activators often associate with histone acetyltransferases (HATs) to increase target gene expression, whereas transcription repressors frequently interact with histone deacetylases (HDACs) to downregulate target gene expression (41) . As coregulators, HDACs have been recently implicated in tissue differentiation. There are several reports that HDACs act as regulators of bone metabolism. BA inhibits the enzymatic activity of HDACs by competing with the HDAC substrate at the enzyme active site pocket containing its catalytic center (5) . BA is able to enhance osteogenesis and the expression of osteoblast marker genes in several types of osteogenic cells, suggesting that modulation of endogenous HDAC enzymatic activity is important for execution of the osteogenic program (38) .
In summary, we have shown that the FRE element in the rat BSP gene promoter mediates the stimulatory effects of BA on BSP gene transcription. Since BSP is expressed specifically in mineralized connective tissues, and BA is a major metabolic product of periodontopathic bacteria, BA may up-or down-regulate bone formation and periodontal tissue regeneration. It is conceivable that BA could be used for periodontal therapy in the future. . DNA-protein complexes were separated on 5% polyacrylamide gel in low-ionic-strength Trisborate buffer, dried under vacuum, and exposed to an imaging plate for quantitation by image analysis.
